Skip to Content
Søk Menu
Hanne Norseth

EHA 2025: TG01 Shows Promise in KRAS-Mutated Myeloma

/ Hanne Norseth
EHA25Myelom Play the Video
Frida Bugge Askeland

EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma

/ Frida Bugge Askeland
EHA25Myelom Play the Video

Fredrik Schjesvold: Bridging Science and Clinical Innovation                                                                                      

/ Jan Andreasen
Myelom

Advancing Myeloma Research and Treatment: An Interview with Fredrik Schjesvold

/ Fredrik Schjesvold / Jan Andreasen
Myelom
Muhammad Kashif

Novel Risk Stratification Method for Bone Disease in Multiple Myeloma Patients Minimizes Radiation Exposure and Lowers Economic Burden

/ Muhammad Kashif
AIASH24Myelom Play the Video
Meletios-Athanasios Dimopoulos

Daratumumab Monotherapy Shows Clinical Benefit for Early Intervention for Patients with High-Risk Smoldering Multiple Myeloma

/ Meletios A. Dimopoulos
ASH24Myelom Play the Video
Frida Bugge Askeland

Positive Outcome of Steroid Replacement in Transplant-Ineligible Myeloma

/ Frida Bugge Askeland
ASH24Myelom Play the Video
Fredrik Schjesvold

ASH 2024 Highlights: Early Smouldering Myeloma Treatment and Breakthrough Therapies in Multiple Myeloma Take Center Stage

/ Fredrik Schjesvold
ASH24Myelom Play the Video
Alex Lesokhin

Elranatamab Demonstrates Sustained Efficacy with Reduced Dosing Frequency in Refractory Multiple Myeloma

/ Alexander Lesokhin
ASH24Myelom Play the Video

The Aquila Study Strongly Supports the Benefit of Early Intervention with Daratumumab Monotherapy in Patients with High-Risk Smoldering Multiple Myeloma

/ Jan Andreasen
ASH24Myelom
Fredrik Schjesvold

The Trispecific Antibody SAR’257 Discontinued After Phase 1 Findings

/ Fredrik Schjesvold
ASH24Myelom Play the Video

Several Trials Showed Improvements in the Treatment of Multiple Myeloma

/ BestPractice Nordic
EHA24Myelom
Hent flere
Back to top